Exelixis, Inc. is an oncology-focused biotechnology company based in California. It lobbies Congress on access, coverage, and payment for cancer drugs, including implementation of the Inflation Reduction Act and programs like 340B, and on tax issues affecting small biotech firms. It has reported four filings totaling $240,000 and used the law firm Arnold & Porter Kaye Scholer LLP.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BOBBY MCMILLIN
The latest disclosures for this client.
ARNOLD & PORTER KAYE SCHOLER LLP
Q2ARNOLD & PORTER KAYE SCHOLER LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
ARNOLD & PORTER KAYE SCHOLER LLP
CASEY BROUHARD
ARNOLD & PORTER KAYE SCHOLER LLP
EUGENIA PIERSON
ARNOLD & PORTER KAYE SCHOLER LLP
mr PETER ERIC DUYSHART
ARNOLD & PORTER KAYE SCHOLER LLP
PARI MODY
ARNOLD & PORTER KAYE SCHOLER LLP
SONJA NESBIT
ARNOLD & PORTER KAYE SCHOLER LLP
DAVID SKILLMAN
ARNOLD & PORTER KAYE SCHOLER LLP
TWINKLE PATEL
ARNOLD & PORTER KAYE SCHOLER LLP
ARNOLD & PORTER KAYE SCHOLER LLP
Q4ARNOLD & PORTER KAYE SCHOLER LLP
Q3ARNOLD & PORTER KAYE SCHOLER LLP
Q2ARNOLD & PORTER KAYE SCHOLER LLP
Q1